Sveriges mest populära poddar

Ozempic’s Success Is Bad News for Rivals

7 min•23 oktober 2023

Bloomberg News Health Reporter Madison Muller discusses how the drug Ozempic could cut demand for big-money drugs targeting a wide range of maladies, even Alzheimer’s.
Hosts: Carol Massar and Tim Stenovec. Producer: Paul Brennan.

See omnystudio.com/listener for privacy information.

Fler avsnitt av Bloomberg Businessweek

Bloomberg Businessweek Weekend - August 28th, 2026

28 aug.•37 min

Warsh Says Inflation Isn’t Slowing, Policymakers Will Bring it Down

28 aug.•36 min

People Without Kids Are Hacking 529 Accounts for a Roth Backdoor

28 aug.•8 min

Nvidia Fuels Bets on AI Trade

27 aug.•42 min

The Mormon Church Is Quietly Expanding Its Real Estate Empire

27 aug.•11 min

Nvidia’s Estimate-Topping Forecast Fails to Impress Investors

26 aug.•42 min

VistaJet US President Leona Qi on Global Private Jet Expansion

26 aug.•11 min

Bessent’s Mentor Stanley Druckenmiller Calls Bond Buying a Mistake

25 aug.•41 min

Trump's Family Joins the Sprint to Get a National Bank Charter

25 aug.•11 min

Bessent Warns Iran’s Trade Partners to Cut Ties or Face Sanctions

24 aug.•42 min

Bloomberg Businessweek med Bloomberg finns tillgänglig på flera plattformar. Informationen på denna sida kommer från offentliga podd-flöden.